Last night’s Master Investor seminar in the City of London on the investment potential of medical cannabis brought a number of key issues into focus, writes Victor Hill.
With Sainsbury’s shares trading at their lowest in 25 years, and with a 5.2% dividend yield on offer, John Kingham investigates whether they are worthy of investors’ attention.
Robert Stephens discusses why the prime housebuilder could offer good value for money following its recent results.
If you are into high price earnings, market leading growth stocks then take a look at Zotefoams, writes Mark Watson-Mitchell.
A buying opportunity has arisen in award-winning British video game developer and publisher Codemasters, writes Mark Watson-Mitchell.
Robert Stephens discusses why an evolving business model could have investment appeal
Mark Watson-Mitchell considers the future of specialist valve manufacturer Pressure Technologies after recent disposals and the appointment of a new nomad.
The acquisition of Stride Gaming looks to be a transformative one for Rank Group, writes Mark Watson-Mitchell.
Robert Stephens discusses why Aviva could deliver high total returns on the back of its restructuring programme.
Stobart Group has been through some hairy old times over the last couple of years or so, but Mark Watson-Mitchell now reckons that the resultant streamlining of its activities will help to catapult its shares upwards.
